Zeifman, Richard J.
Spriggs, Meg J.
Kettner, Hannes
Lyons, Taylor
Rosas, Fernando E.
Mediano, Pedro A. M.
Erritzoe, David https://orcid.org/0000-0002-7022-6211
Carhart-Harris, Robin L.
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research
Article History
Received: 9 November 2022
Accepted: 12 January 2023
First Online: 29 January 2025
Competing interests
: RJZ is a post-doctoral fellow in the NYU Langone Psychedelic Medicine Research Training program funded by MindMed. DE is a paid advisor for Mydecine, Entheon, SmallPharma Ltd, and Field Trip Healthcare. RCH is a scientific advisor to Usona Institute, Synthesis Institute, Mydecine, Maya Health, Osmind, Entheon, Beckley Psychtech, TRYP therapeutics, Journey Collab and Journey Space. MJS, HK, TL, FER, and PM report no conflicts of interest.